A Clinical Trial of Infliximab for Childhood Uveitis

Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial

NCT02298062 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

NCT00076726 ·Status: TERMINATED ·Phase: PHASE2

A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD

NCT06843408 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease

NCT00760435 ·Status: COMPLETED ·Phase: PHASE3

Tocilizumab for the Treatment of Refractory Behcet's Uveitis

NCT03554161 ·Status: TERMINATED ·Phase: PHASE2

Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis

NCT00033891 ·Status: COMPLETED ·Phase: PHASE2

Golimumab for the Treatment of Refractory Behcet's Uveitis

NCT04218565 ·Status: TERMINATED ·Phase: PHASE2

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis

NCT05384249 ·Status: TERMINATED ·Phase: PHASE2

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

NCT00574470 ·Status: COMPLETED ·Phase: PHASE4

Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children

NCT06530004 ·Status: RECRUITING

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

NCT07124078 ·Status: RECRUITING ·Phase: PHASE2

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

NCT01802593 ·Status: TERMINATED ·Phase: PHASE4

Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency

NCT03733067 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

NCT00056264 ·Status: COMPLETED ·Phase: PHASE3

Rituximab Trial for Pediatric Nephrotic Syndrome

NCT01716442 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Infliximab in the Treatment of Patients With Severe COVID-19 Disease

NCT04922827 ·Status: COMPLETED ·Phase: PHASE2

Infusion Related Reactions in Patients Receiving Infliximab

NCT02332460 ·Status: UNKNOWN

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

NCT06663722 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

NCT05651880 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease

NCT06263478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

NCT05897008 ·Status: COMPLETED ·Phase: PHASE1

Tocilizumab for Relapsing Polychondritis

NCT01104480 ·Status: WITHDRAWN ·Phase: PHASE2

Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

NCT01148797 ·Status: COMPLETED ·Phase: PHASE2

A Study of Infliximab in Patients With Sarcoidosis

NCT00073437 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis

NCT01818492 ·Status: COMPLETED ·Phase: PHASE2/PHASE3